Virginia Tech to honor class of 2020 and 2021 at spring commencement Photo courtesy Janay Reece (FILE) (Source: Janay Reece) By Janay Reece | May 10, 2021 at 6:43 PM EDT - Updated May 10 at 6:43 PM
BLACKSBURG, Va. (WDBJ) - It’s a day thousands have been waiting for graduation.
Virginia Tech will hold in-person commencement ceremonies in Lane Stadium May 10 through May 16. The university plans to celebrate graduating seniors, graduate school students, and their families, all while also adhering to public health guidelines.
The university will hold 16 in-person ceremonies at Lane Stadium. Graduates have been allowed to have four guests each.
Virginia Tech Facilities worked for about a week to get Lane Stadium ready. They layed out 650 chairs, each 10 feet apart and marked guests’ seats.
Researchers receive $3.75 million to study the impact of fluid flow on CAR-T cell therapy for brain cancer
Glioblastoma multiforme is among the most lethal of cancers and the most stubborn in the face of treatment. Fewer than 20 percent of patients survive more than two years after diagnosis, according to the Central Brain Tumor Registry of the United States.
But a team of researchers at Fralin Biomedical Research Institute at VTC and City of Hope, a comprehensive care center, believes the complex way fluid flows through glioblastoma tumors holds the key to the therapy s success. They believe they can use that flow to improve chimeric antigen receptor T cell therapy (CAR-T) and help more patients survive.
E-Mail
IMAGE: Jennifer Munson and her lab at the Fralin Biomedical Research Institute at VTC will build tissue-engineered model tumors to test how fluid flow can be manipulated to improve CAR-T cell. view more
Credit: Clayton Metz/Virginia Tech
Glioblastoma multiforme is among the most lethal of cancers and the most stubborn in the face of treatment. Fewer than 20 percent of patients survive more than two years after diagnosis, according to the Central Brain Tumor Registry of the United States.
But a team of researchers at Fralin Biomedical Research Institute at VTC and City of Hope, a comprehensive care center, believes the complex way fluid flows through glioblastoma tumors holds the key to the therapy s success. They believe they can use that flow to improve chimeric antigen receptor T cell therapy (CAR-T) and help more patients survive.